-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Risperidone in Schizophrenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Risperidone in Schizophrenia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Risperidone in Schizophrenia Drug Details: DLP-114 (risperidone is 6-12 month formulation) is under...
-
Product Insights
DLP RE / JMJ Dev – Fort Worth Rental Housing Development – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our DLP RE / JMJ Dev - Fort Worth Rental Housing Development - Texas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Company Profile
Delek Logistics Partners LP – Company Profile
Delek Logistics Partners LP (DLP), a subsidiary of Delek US Holdings Inc, is a crude oil transportation company. The company owns, operates, acquires and constructs the logistics and marketing assets of crude oil and intermediate and refined products pipeline. It also gathers, transports, offloads and stores crude oil. DLP stores intermediate products, refined products, and feed stocks and carries out the marketing, wholesale and distribution of crude oil. The company also stores crude oil in selected regions of the southeastern...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – risperidone
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry risperidone Drug Details DLP-114 (risperidone is 6-12 month formulation) is under development for the...